We observed an increase in activating receptor NKp30 expression on immunomodulatory, weakly cytotoxic CD56bright NK cell subsets in the TB and TB/HIV groups compared to healthy controls, potentially increasing the recognition and response against Mtb and HIV-infected cells. The gene discussed is NCR3; the disease is tuberculosis.